• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5,834
2,301
2,207
2,091
1,939

COUNTRY

1,076
856
274
248
225

CATEGORIES

  • 929
  • 170
  • 113
  • 287
    • 49
  • 473
  • 228
  • 237
  • 53
  • 63
  • 812
  • 1,448
  • 822
  • 18
  • 449
  • 1,389
  • 2,312
    • 82
    • 121
    • 66
    • 66
    • 36
    • 37
    • 11
    • 11
    • 12
    • 18
  • 23
  • 262
  • 39

PRICE

5,799
13,001
21,558
26,507

PUBLISHED

1,789
4,966
10,445
26,507

PRODUCT TYPE

21,872
2,394
1,022
935
164
55
21
19
14
6
4
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Depilatories in Nigeria Depilatories in Nigeria - Product Thumbnail Image

Depilatories in Nigeria

Demand for depilatories is still fairly low in Nigeria, but with increased Westernisation and rising incomes, consumers are spending more on such products. The category also benefited from widening...

September 2014
FROM

Genital Herpes - Pipeline Review, H2 2014

Genital Herpes - Pipeline Review, H2 2014 Summary This, ‘Genital Herpes - Pipeline Review, H2 2014’, provides an overview of the Genital Herpes’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Cerebral Palsy - Pipeline Review, H2 2014

Cerebral Palsy - Pipeline Review, H2 2014 Summary This, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Epidermolysis Bullosa - Pipeline Review, H2 2014

Epidermolysis Bullosa - Pipeline Review, H2 2014 Summary This, ‘Epidermolysis Bullosa - Pipeline Review, H2 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic pipeline. This report...

September 2014
FROM

House Dust Mite Allergy - Pipeline Review, H2 2014

House Dust Mite Allergy - Pipeline Review, H2 2014 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H2 2014’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

September 2014
FROM

Vitiligo - Pipeline Review, H2 2014

Vitiligo - Pipeline Review, H2 2014 Summary This, ‘Vitiligo - Pipeline Review, H2 2014’, provides an overview of the Vitiligo’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Secondary Hyperparathyroidism - Pipeline Review, H2 2014

Secondary Hyperparathyroidism - Pipeline Review, H2 2014 Summary This, ‘Secondary Hyperparathyroidism - Pipeline Review, H2 2014’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic...

September 2014
FROM

Post Menopausal Osteoporosis - Pipeline Review, H2 2014

Post Menopausal Osteoporosis - Pipeline Review, H2 2014 Summary This, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2014’, provides an overview of the Post Menopausal Osteoporosis’s therapeutic...

September 2014
FROM

Pulmonary Tuberculosis - Pipeline Review, H2 2014

Pulmonary Tuberculosis - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Tuberculosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Tuberculosis’s therapeutic pipeline. This...

September 2014
FROM

Hairy Cell Leukemia - Pipeline Review, H2 2014

Hairy Cell Leukemia - Pipeline Review, H2 2014 Summary This, ‘Hairy Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the Hairy Cell Leukemia’s therapeutic pipeline. This report...

September 2014
FROM

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary This, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Refractory...

September 2014
FROM

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing Multiple Sclerosis...

September 2014
FROM

Chelating Agent Market by Type, Application, & Geography - Global Trend & Forecast to 2019

Chelating Agent Market by Type (Aminopolycarboxylate, Phosphate & Phosphonate, Biodegradable), Application (Cleaner, Water Treatment, Pulp & Paper, Agrochemical, Personal care, Pharmaceutical, Food...

September 2014
FROM

The Asia Pacific Markets For PCR Technologies

During the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still...

September 2014
FROM
Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins - Product Thumbnail Image

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment...

September 2014
FROM

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia...

September 2014
FROM

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data...

September 2014
FROM

Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014

Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014" provides...

September 2014
FROM

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic...

September 2014
FROM

Hyperemia Global Clinical Trials Review, H2, 2014

Hyperemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This...

September 2014
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S